홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Hydrochloric Acid → 4-Vinylsulfonyl-morpholine

HRID 272548
인쇄

반응식

HRID 272548 반응식
C1C2[C:10]3=[CH:12]C4C=CC(C(N)=O)=[CH:17][C:18]=4[N:9]3CC=CC=2C=CC=1.C1C2C3=CC4C=C[C:37]([C:40](O)=O)=CC=4N3CC=CC=2C=CC=1.[OH-:43].[Na+].Cl.C(Cl)(=O)C(Cl)=O.CCN(P1(N(C)CCCN1C)=NC(C)(C)C)CC.CN[S:72](NC)(=[O:74])=[O:73]>C(Cl)Cl.CO.C1COCC1>[CH:37]([S:72]([N:9]1[CH2:10][CH2:12][O:43][CH2:17][CH2:18]1)(=[O:74])=[O:73])=[CH2:40]
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

10

반응물 7

HCID 313Hydrochloric Acid2회HCID 14798Sodium HydroxideHCID 65578Oxalyl chlorideHCID 89736N,N'-DimethylsulfamideHCID 35138512-((1,1-Dimethylethyl)imino)-N,N-diethylhexahydro-1,3-dimethyl-2lambda5-1,3,2-diazaphosphorin-2-amineHCID 666396797H-indolo[2,1-a][2]benzazepine-10-carboxylic acid
HCID 66639690
7H-indolo[2,1-a][2]benzazepine-10-carboxamide

생성물 1

HCID 159145184-Vinylsulfonyl-morpholine수율 71%

시약·촉매·용매 2

HCID 6344Dichloromethane용매2회HCID 21899815MeOH tetrahydrofuran용매

반응 조건

온도
22 °C

실험 절차

7H-Indolo[2,1-a][2]benzazepine-10-carboxamide, 13-cyclohexyl-N-[(dimethylamino)sulfonyl]-3-methoxy-6-(4-morpholinylsulfonyl)-. To a solution of 7H-Indolo[2,1-a][2]benzazepine-10-carboxylic acid, 13-cyclohexyl-3-methoxy-6-(4-morpholinylsulfonyl)-, methyl ester (60 mg, 0.11 mmol) in 1:1 MeOH/THF (2.0 mL) was added 1M NaOH (2.0 mL). The resulting mixture was stirred at 22° C. for 16 hr. 1M HCl (15 mL) was added and the aqueous layer was extracted with CHCl3 (2×15 mL). The organic phase was dried over Na2SO4, filtered, and concentrated under reduced pressure to afford a white solid. This solid was dissolved in CH2Cl2 (1.0 mL) and 2M oxalyl chloride (1.0 mL) in CH2Cl2 was added. This solution was stirred at 22° C. for 2 hr and concentrated under reduced pressure. The resulting yellow oil was redissolved in CH2Cl2 (1.0 mL); BEMP (60 mg, 0.22 mmol) and dimethylsulfamide (68 mg, 0.55 mmol) were added. The resulting mixture was allowed to stir at 22° C. for 6 hr. 1M HCl (15 mL) was added and the aqueous layer was extracted with CHCl3 (2×30 mL). The organic phase was concentrated under reduced pressure. This oil was purified by reverse-phase prep HPLC to afford the title compound (50 mg, 71%) as a yellow paste. MS 643 m/z (MH+). 1H NMR (300 MHz, CDCl3) δ ppm 1.15-1.60 (m, 4H), 1.80 (m, 1H), 1.91-2.12 (m, 5H), 2.81 (m, 3H), 3.08 (broad s, 8H), 3.22 (m, 2H), 3.41 (m, 2H), 3.92 (s, 3H), 4.4 (broad d, 1H), 5.36 (broad d, 1H), 7.02 (d, 1H), 7.15 (m, 1H), 7.40 (m, 1H), 7.51 (m, 1H), 7.68 (s, 1H), 7.90 (m, 1H), 8.11 (s, 1H), 8.58 (s, 1H).

후처리

  1. extractionthe aqueous layer was extracted with CHCl3 (2×15 mL)
  2. dry with materialThe organic phase was dried over Na2SO4
  3. filtrationfiltered
  4. concentrationconcentrated under reduced pressure
  5. customto afford a white solid
  6. stirringThis solution was stirred at 22° C. for 2 hr
  7. concentrationconcentrated under reduced pressure
  8. dissolutionThe resulting yellow oil was redissolved in CH2Cl2 (1.0 mL)
  9. stirringto stir at 22° C. for 6 hr
  10. extractionthe aqueous layer was extracted with CHCl3 (2×30 mL)
  11. concentrationThe organic phase was concentrated under reduced pressure
  12. customThis oil was purified by reverse-phase prep HPLC

출처 및 근거

ORD 기록
ord-9005c5b5ea0849baadd1aedd86b42931
출처 데이터셋
uspto-grants-2008_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07456167B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트